1 / 7

Liquid Biopsy Market

Liquid Biopsy Market

IRFAN13
Download Presentation

Liquid Biopsy Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Liquid Biopsy Market by Type, Application, Element - Global Trends and Forecast to 2027 © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  2. Global Liquid Biopsy Market t • The liquid biopsy market is projected to exhibit robust expansion by 2027 owing to growing preference for non-invasive diagnostic methods among patients across the world. • Liquid biopsy refers to a blood test that looks for cancer cells from a tumor that are circulating in the blood or DNA fragments from tumor cells, which are present in the blood. It has been shown to aid in the detection of cancer even in the early stages. Additionally, it is also used to help plan treatment, understand how well treatment is working, and determine if cancer has returned. Rising awareness among patients, particularly high-risk individuals, about early disease diagnosis and periodic checkups has fostered industry uptake in recent years. • To access a sample copy or view the market report in detail along with the table of • contents, please click the link below: https://www.gminsights.com/request-sample/detail/3775 © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  3. Continue:- • Furthermore, industry players have been actively employing lucrative strategies to gain a competitive edge in the emerging sector, which has positively impacted liquid biopsy market dynamics. For instance, in November 2021, Lucence Health, a leading precision oncology company, entered into a partnership agreement with VA Palo Alto Healthcare System, a prominent oncology firm, to launch its first liquid biopsy technology study in the U.S. The study intends to examine the use of non-invasive liquid biopsy in conjunction with imaging technologies for the detection of lung cancer in high-risk individuals. • The liquid biopsy market has been segregated on the basis of application, biomarkers, product, and region. In terms of biomarkers, the market has further been divided into circulating tumor DNA, circulating tumor cells (CTC), and others. • The circulating tumor cells (CTC) sub-segment is expected to reach a notable valuation by 2027, expanding at approximately 29.7% CAGR over the study timeline propelled by the high specificity of CTC. Moreover, increased risk of metastatic conditions, along with organizational efforts to expand accessibility, is likely to drive segmental growth in the coming years. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  4. 360° Industry Analysis • Browse key industry insights spread across 130 pages with 157 market data tables & 13 figures & charts from the report,“Liquid Biopsy Market Size By Biomarkers (Circulating Tumor Cells [CTC], Circulating Tumor DNA [ctDNA]), By Product (Kits & Reagents, Assay & Panels), By Application (Lung Cancer, Breast Cancer, Colorectal cancer, Prostate Cancer), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:https://www.gminsights.com/industry-analysis/liquid-biopsy-market • With respect to application, the market has been categorized into prostate cancer, lung cancer, colorectal cancer, breast cancer, and others. In 2020, the prostate cancer sub-segment held over 9% share in the liquid biopsy market and is estimated to witness steady growth over the analysis period. Higher disease prevalence in developing countries has prompted the adoption of advanced diagnostic methods, which is slated to fuel segmental demand in coming years. • From the regional point of view, the Latin America liquid biopsy market is poised to grow at a CAGR of around 29.4% over the assessment timeline. regional market growth over the forthcoming years. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  5. Partial Table of Contents (ToC) of the report: • Chapter 1   Methodology • 1.1    Market definitions • 1.2    Base estimates & working • 1.2.1    North America • 1.2.2    Europe • Chapter 2   Executive Summary • 2.1    Liquid biopsy industry 3600 synopsis, 2016 – 2027 (USD Million) • 2.1.1    Business trends • 2.1.2    Biomarkers trends • 2.1.3    Product trends • 2.1.4    Application trends © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  6. Key Playes: • F. Hoffmann-La Roche Ltd., • BIOCEPT, Inc.,  • QIAGEN,  • Myriad Genetics, Inc., • Guardant Health, Inc.,  • Illumina, Inc., • Lucence health Inc.,  • Browse complete table of content of this report@ https://www.gminsights.com/industry-analysis/liquid-biopsy-market © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  7. Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

More Related